MARY NIXON: Open Payments
NPI 1528830643 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: UZEDY, FANAPT, ABILIFY MAINTENA, INGREZZA, SPRAVATO, REXULTI, Jornay PM, Auvelity.
Industry payments across KS — which companies pay providers there.
